$WVE
Wave Life Sciences Ltd.

2016 Q2 Form 10-Q Financial Statement

#000119312516591982 Filed on May 16, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2016 Q1 2015 Q1
Revenue $417.0K $0.00 $26.00K
YoY Change 230.95% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.650M $3.220M $1.880M
YoY Change 91.1% 71.28%
% of Gross Profit
Research & Development $8.401M $4.736M $1.607M
YoY Change 354.11% 194.71%
% of Gross Profit
Depreciation & Amortization $190.0K $153.0K $90.00K
YoY Change 111.11% 70.0%
% of Gross Profit
Operating Expenses $12.06M $7.952M $3.491M
YoY Change 221.04% 127.79% 260.64%
Operating Profit -$11.64M -$7.952M -$3.465M
YoY Change 220.69% 129.49%
Interest Expense $106.0K $104.0K
YoY Change -806.67%
% of Operating Profit
Other Income/Expense, Net $121.0K $100.0K $50.00K
YoY Change -650.0% 100.0%
Pretax Income -$11.52M -$7.852M -$3.415M
YoY Change 215.45% 129.93%
Income Tax $48.00K -$5.000K $50.00K
% Of Pretax Income
Net Earnings -$11.57M -$7.847M -$3.465M
YoY Change 212.57% 126.46% 766.25%
Net Earnings / Revenue -2773.38% -13326.92%
Basic Earnings Per Share
Diluted Earnings Per Share -$509.5K -$364.3K -$419.6K
COMMON SHARES
Basic Shares Outstanding 23.43M shares 21.55M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $181.8M $153.4M
YoY Change 2230.77%
Cash & Equivalents $181.8M $153.4M $10.96M
Short-Term Investments
Other Short-Term Assets $2.200M $600.0K
YoY Change 175.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $183.9M $154.0M
YoY Change 2038.85%
LONG-TERM ASSETS
Property, Plant & Equipment $5.093M $3.218M
YoY Change 182.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.300M $1.300M
YoY Change 18.18%
Total Long-Term Assets $6.397M $4.522M
YoY Change 113.23%
TOTAL ASSETS
Total Short-Term Assets $183.9M $154.0M
Total Long-Term Assets $6.397M $4.522M
Total Assets $190.3M $158.5M
YoY Change 1540.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.899M $2.437M
YoY Change 85.67%
Accrued Expenses $2.200M $1.300M
YoY Change 1000.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K
YoY Change 0.0%
Total Short-Term Liabilities $8.647M $3.770M
YoY Change 245.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $100.0K
YoY Change -100.0%
Other Long-Term Liabilities $409.0K $295.0K
YoY Change
Total Long-Term Liabilities $7.539M $357.0K
YoY Change 7439.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.647M $3.770M
Total Long-Term Liabilities $7.539M $357.0K
Total Liabilities $16.19M $4.127M
YoY Change 522.54%
SHAREHOLDERS EQUITY
Retained Earnings -$54.49M -$42.92M
YoY Change
Common Stock $215.4M $185.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $166.3M $146.5M
YoY Change
Total Liabilities & Shareholders Equity $190.3M $158.5M
YoY Change 1540.84%

Cashflow Statement

Concept 2016 Q2 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$11.57M -$7.847M -$3.465M
YoY Change 212.57% 126.46% 766.25%
Depreciation, Depletion And Amortization $190.0K $153.0K $90.00K
YoY Change 111.11% 70.0%
Cash From Operating Activities $390.0K -$7.140M -$1.620M
YoY Change -128.06% 340.74%
INVESTING ACTIVITIES
Capital Expenditures -$870.0K $685.0K $17.00K
YoY Change 141.67% 3929.41%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$60.00K
YoY Change -100.0%
Cash From Investing Activities -$870.0K -$690.0K -$70.00K
YoY Change -36.03% 885.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.63M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.94M -20.00K 11.63M
YoY Change 144600.0% -100.17%
NET CHANGE
Cash From Operating Activities 390.0K -7.140M -1.620M
Cash From Investing Activities -870.0K -690.0K -70.00K
Cash From Financing Activities 28.94M -20.00K 11.63M
Net Change In Cash 28.46M -7.850M 9.940M
YoY Change -1142.49% -178.97%
FREE CASH FLOW
Cash From Operating Activities $390.0K -$7.140M -$1.620M
Capital Expenditures -$870.0K $685.0K $17.00K
Free Cash Flow $1.260M -$7.825M -$1.637M
YoY Change -222.33% 378.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23426423 shares
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10961000
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21551423 shares
CY2016Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21551423 shares
CY2016Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
357000
CY2016Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1271000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
146521000
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
295000
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4048000
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2437000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42923000
CY2016Q1 us-gaap Liabilities
Liabilities
4127000
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
158522000
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
185344000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3770000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
52000
CY2016Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
62000
CY2016Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
62000
CY2016Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
192000
CY2016Q1 us-gaap Assets
Assets
158522000
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3218000
CY2016Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1055000
CY2016Q1 us-gaap Assets Current
AssetsCurrent
154000000
CY2016Q1 us-gaap Other Assets
OtherAssets
57000
CY2016Q1 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
23000
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
580000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153397000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1048000
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21551423 shares
CY2015Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21551423 shares
CY2015Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
241000
CY2015Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
945000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
153491000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
163000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3182000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2811000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35076000
CY2015Q4 us-gaap Liabilities
Liabilities
4059000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
165424000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
185344000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3818000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
41000
CY2015Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
62000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
78000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
192000
CY2015Q4 us-gaap Assets
Assets
165424000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2789000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1055000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
161384000
CY2015Q4 us-gaap Other Assets
OtherAssets
4000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
18000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
146000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161220000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1619000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8273805 shares
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-3465000
CY2015Q1 us-gaap Revenues
Revenues
26000
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
50000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3465000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
50000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
50000
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31000
CY2015Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
55000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3493000
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-28000
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3415000
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1846000
CY2015Q1 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-30000
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-26000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9913000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
3491000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-72000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
11631000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1607000
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11631000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-251000
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1846000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1884000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
249000
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
89000
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
-27000
CY2015Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
50000
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7136000
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001631574
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
WAVE LIFE SCIENCES LTD.
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-7847000
CY2016Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
104000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
414000
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7952000
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Trading Symbol
TradingSymbol
WVE
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21551423 shares
CY2016Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
16000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
685000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
100000
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
53000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7836000
CY2016Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11000
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7852000
CY2016Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
185000
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
866000
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-5000
CY2016Q1 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
136000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7823000
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
7952000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-685000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-16000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4736000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
329000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
866000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3216000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-296000
CY2016Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
153000
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
14000
CY2016Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5000

Files In Submission

Name View Source Status
0001193125-16-591982-index-headers.html Edgar Link pending
0001193125-16-591982-index.html Edgar Link pending
0001193125-16-591982.txt Edgar Link pending
0001193125-16-591982-xbrl.zip Edgar Link pending
d179788d10q.htm Edgar Link pending
d179788dex311.htm Edgar Link pending
d179788dex312.htm Edgar Link pending
d179788dex321.htm Edgar Link pending
d179788dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wve-20160331.xml Edgar Link completed
wve-20160331.xsd Edgar Link pending
wve-20160331_cal.xml Edgar Link unprocessable
wve-20160331_def.xml Edgar Link unprocessable
wve-20160331_lab.xml Edgar Link unprocessable
wve-20160331_pre.xml Edgar Link unprocessable